Eli Lilly In-Licenses Non-Opioid Drug from Centrexion in $997 Million-Plus Deal 0 28.05.2019 03:00 Feedity.com Eli Lilly announced it has inked a license agreement with Centrexion Therapeutics to acquire the exclusive global rights to CNTX-0290. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
